{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:52:52Z","timestamp":1792615972577,"version":"4.5.0"},"reference-count":42,"publisher":"MyJove Corporation","issue":"181","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/63186","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T19:00:05Z","timestamp":1646766005000},"source":"Crossref","is-referenced-by-count":3,"title":["A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis"],"prefix":"10.3791","author":[{"given":"Arman Alberto Sorin","family":"Shadaloey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alcida","family":"Karz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana S.","family":"Moubarak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Levinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kleffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Aristizabal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef Z.","family":"Wadghiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hernando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"issue":"3","key":"ref1","first-page":"209","type":"journal-article","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 71 (3), 209-249 (2021).","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/pcmr.12544","type":"journal-article","article-title":"Metastatic pathways in patients with cutaneous melanoma","volume":"30","author":"Adler","year":"2017","unstructured":"Adler, N. R., Haydon, A., McLean, C. A., Kelly, J. W., Mar, V. J. Metastatic pathways in patients with cutaneous melanoma. Pigment Cell Melanoma Research. 30 (1), 13-27 (2017).","journal-title":"Pigment Cell Melanoma Research"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","type":"journal-article","article-title":"Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site","volume":"1","author":"Platz","year":"2008","unstructured":"Platz, A., Egyhazi, S., Ringborg, U., Hansson, J. Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. Molecular Oncology. 1 (4), 395-405 (2008).","journal-title":"Molecular Oncology"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-06-3481","type":"journal-article","article-title":"A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis","volume":"67","author":"Alonso","year":"2007","unstructured":"Alonso, S. R. et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Research. 67 (7), 3450-3460 (2007).","journal-title":"Cancer Research"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ajd.12348","type":"journal-article","article-title":"Clinical and biological determinants of melanoma progression: Should all be considered for clinical management","volume":"57","author":"Rowe","year":"2016","unstructured":"Rowe, C. J., Khosrotehrani, K. Clinical and biological determinants of melanoma progression: Should all be considered for clinical management? Australasian Journal of Dermatology. 57 (3), 175-181 (2016).","journal-title":"Australasian Journal of Dermatology"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41467-017-01433-3","type":"journal-article","article-title":"Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche","volume":"8","author":"Plebanek","year":"2017","unstructured":"Plebanek, M. P. et al. Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche. Nature Communications. 8 (1), 1319 (2017).","journal-title":"Nature Communications"},{"issue":"47","key":"ref7","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1038\/onc.2009.284","type":"journal-article","article-title":"Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma","volume":"28","author":"Orgaz","year":"2009","unstructured":"Orgaz, J. L. et al. Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma. Oncogene. 28 (47), 4147-4161 (2009).","journal-title":"Oncogene"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1593\/neo.11446","type":"journal-article","article-title":"Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis","volume":"13","author":"Ladhani","year":"2011","unstructured":"Ladhani, O., Sanchez-Martinez, C., Orgaz, J. L., Jimenez, B., Volpert, O. V. Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis. Neoplasia. 13 (7), 633-642 (2011).","journal-title":"Neoplasia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fmed.2018.00307","type":"journal-article","article-title":"The role of melanoma cell-stroma interaction in cell motility, invasion, and metastasis","volume":"5","author":"Ju","year":"2018","unstructured":"Ju, R. J., Stehbens, S. J., Haass, N. K. The role of melanoma cell-stroma interaction in cell motility, invasion, and metastasis. Frontires in Medicine - Dermatology. 5, 307 (2018).","journal-title":"Frontiers in Medicine - Dermatology"},{"issue":"21","key":"ref10","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/jnci\/93.21.1638","type":"journal-article","article-title":"Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma","volume":"93","author":"Wiley","year":"2001","unstructured":"Wiley, H. E., Gonzalez, E. B., Maki, W., Wu, M. T., Hwang, S. T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. Journal of the National Cancer Institute. 93 (21), 1638-1643 (2001).","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","type":"journal-article","article-title":"Metastatic pathways and time courses in the orderly progression of cutaneous melanoma","volume":"147","author":"Meier","year":"2002","unstructured":"Meier, F. et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. British Journal of Dermatology. 147 (1), 62-70 (2002).","journal-title":"British Journal of Dermatology"},{"issue":"5-6","key":"ref12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10585-018-9893-y","type":"journal-article","article-title":"Genetics of metastasis: melanoma and other cancers","volume":"35","author":"Turner","year":"2018","unstructured":"Turner, N., Ware, O.,Bosenberg, M. Genetics of metastasis: melanoma and other cancers. Clinical & Experimental Metastasis. 35 (5-6), 379-391 (2018).","journal-title":"Clinical & Experimental Metastasis"},{"issue":"7823","key":"ref13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","type":"journal-article","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","unstructured":"Ubellacker, J. M. et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 585 (7823), 113-118 (2020).","journal-title":"Nature"},{"issue":"5547","key":"ref14","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1126\/science.1064829","type":"journal-article","article-title":"Taking cell-matrix adhesions to the third dimension","volume":"294","author":"Cukierman","year":"2001","unstructured":"Cukierman, E., Pankov, R., Stevens, D. R., Yamada, K. M. Taking cell-matrix adhesions to the third dimension. Science. 294 (5547), 1708-1712 (2001).","journal-title":"Science"},{"issue":"5042","key":"ref15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1126\/science.1549777","type":"journal-article","article-title":"Actin-binding protein requirement for cortical stability and efficient locomotion","volume":"255","author":"Cunningham","year":"1992","unstructured":"Cunningham, C. C. et al. Actin-binding protein requirement for cortical stability and efficient locomotion. Science. 255 (5042), 325-327 (1992).","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2014.10.015","type":"journal-article","article-title":"Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development","volume":"79-80","author":"Unger","year":"2014","unstructured":"Unger, C. et al. Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development. Advanced Drug Delivery Reviews. 79- 80, 50-67 (2014).","journal-title":"Advanced Drug Delivery Reviews"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biomaterials.2016.08.052","type":"journal-article","article-title":"Heralding a new paradigm in 3D tumor modeling","volume":"108","author":"Fong","year":"2016","unstructured":"Fong, E. L., Harrington, D. A., Farach-Carson, M. C., Yu, H. Heralding a new paradigm in 3D tumor modeling. Biomaterials. 108, 197-213 (2016).","journal-title":"Biomaterials"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0024-3205(01)01454-0","type":"journal-article","article-title":"Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model","volume":"70","author":"Nakamura","year":"2002","unstructured":"Nakamura, K. et al. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model. Life Science. 70 (7), 791-798 (2002).","journal-title":"Life Science"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/pcmr.12498","type":"journal-article","article-title":"The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations","volume":"29","author":"Meeth","year":"2016","unstructured":"Meeth, K., Wang, J. X., Micevic, G., Damsky, W., Bosenberg, M. W. The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations. Pigment Cell Melanoma Research. 29 (5), 590-597 (2016).","journal-title":"Pigment Cell Melanoma Research"},{"issue":"16","key":"ref20","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1158\/0008-5472.CAN-11-2837","type":"journal-article","article-title":"BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy","volume":"72","author":"Koya","year":"2012","unstructured":"Koya, R. C. et al. BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy. Cancer Research. 72 (16), 3928-3937 (2012).","journal-title":"Cancer Research"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/pcmr.12220","type":"journal-article","article-title":"Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032","volume":"27","author":"Jenkins","year":"2014","unstructured":"Jenkins, M. H. Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032. Pigment Cell Melanoma Research. 27 (3), 495-501 (2014).","journal-title":"Pigment Cell Melanoma Research"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI94295","type":"journal-article","article-title":"SMAD signaling promotes melanoma metastasis independently of phenotype switching","volume":"129","author":"Tuncer","year":"2019","unstructured":"Tuncer, E. et al. SMAD signaling promotes melanoma metastasis independently of phenotype switching. The Journal of Clinical Investigation. 129 (7), 2702-2716 (2019).","journal-title":"The Journal of Clinical Investigation"},{"issue":"15","key":"ref23","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1158\/0008-5472.CAN-16-0485","type":"journal-article","article-title":"Incipient Melanoma Brain Metastases Instigate Astrogliosis and Neuroinflammation","volume":"76","author":"Schwartz","year":"2016","unstructured":"Schwartz, H. et al. Incipient Melanoma Brain Metastases Instigate Astrogliosis and Neuroinflammation. Cancer Research. 76 (15), 4359-4371 (2016).","journal-title":"Cancer Research"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41591-020-0818-3","type":"journal-article","article-title":"Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy","volume":"26","author":"Perez-Guijarro","year":"2020","unstructured":"Perez-Guijarro, E. et al. Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy. Nature Medicine. 26 (5), 781-791 (2020).","journal-title":"Nature Medicine"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.celrep.2017.10.021","type":"journal-article","article-title":"A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma","volume":"21","author":"Krepler","year":"2017","unstructured":"Krepler, C. et al. A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. Cell Reports. 21 (7), 1953-1967 (2017).","journal-title":"Cell Reports"},{"issue":"6","key":"ref26","first-page":"804","type":"journal-article","article-title":"A systems biology approach identifies FUT8 as a driver of melanoma metastasis","volume":"31","author":"Agrawal","year":"2017","unstructured":"Agrawal, P. et al. A systems biology approach identifies FUT8 as a driver of melanoma metastasis. Cancer Cell. 31 (6), 804-819.e7 (2017).","journal-title":"Cell"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ccell.2019.12.007","type":"journal-article","article-title":"Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis","volume":"37","author":"Hanniford","year":"2020","unstructured":"Hanniford, D. et al. Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis. Cancer Cell. 37 (1), 55-70.e15 (2020).","journal-title":"Cancer Cell"},{"issue":"551","key":"ref28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz5683","type":"journal-article","article-title":"PRMT5 control of cGAS\/STING and NLRC5 pathways defines melanoma response to antitumor immunity","volume":"12","author":"Kim","year":"2020","unstructured":"Kim, H. et al. PRMT5 control of cGAS\/STING and NLRC5 pathways defines melanoma response to antitumor immunity. Science Translational Medicine. 12 (551), eaaz5683 (2020).","journal-title":"Science Translational Medicine"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1755-148X.2012.00994.x","type":"journal-article","article-title":"Development of five new melanoma low passage cell lines representing the clinical and genetic profile of their tumors of origin","volume":"25","author":"de Miera","year":"2012","unstructured":"de Miera, E. V., Friedman, E. B., Greenwald, H. S., Perle, M. A., Osman, I. Development of five new melanoma low passage cell lines representing the clinical and genetic profile of their tumors of origin. Pigment Cell Melanoma Research. 25 (3), 395-397 (2012).","journal-title":"Pigment Cell Melanoma Research"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/pcmr.12114","type":"journal-article","article-title":"Development and characterization of a clinically relevant mouse model of melanoma brain metastasis","volume":"26","author":"Morsi","year":"2013","unstructured":"Morsi, A., et al. Development and characterization of a clinically relevant mouse model of melanoma brain metastasis. Pigment Cell Melanoma Research. 26 (5), 743-745 (2013).","journal-title":"Pigment Cell Melanoma Research"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/onc.2010.523","type":"journal-article","article-title":"Efficient in vivo microRNA targeting of liver metastasis","volume":"30","author":"Huynh","year":"2011","unstructured":"Huynh, C., et al. Efficient in vivo microRNA targeting of liver metastasis. Oncogene. 30 (12), 1481-1488 (2011).","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.omtm.2020.05.033","type":"journal-article","article-title":"Experimental variables that affect human hepatocyte AAV transduction in liver chimeric mice","volume":"18","author":"Zou","year":"2020","unstructured":"Zou, C. et al. Experimental variables that affect human hepatocyte AAV transduction in liver chimeric mice. Molecular Therapy Methods and Clinical Development. 18, 189-198 (2020).","journal-title":"Molecular Therapy Methods and Clinical Development"},{"key":"ref33","first-page":"854885","type":"journal-article","article-title":"Melanoma-secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis","author":"Kleffman","year":"2019","unstructured":"Kleffman, K., et al. Melanoma-secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis. bioRxiv. 854885 (2019).","journal-title":"bioRxiv"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s11307-010-0440-8","type":"journal-article","article-title":"Temporal variations of skin pigmentation in C57BL\/6 mice affect optical bioluminescence quantitation","volume":"13","author":"Curtis","year":"2011","unstructured":"Curtis, A., Calabro, K., Galarneau, J. R., Bigio, I. J. Krucker, T. Temporal variations of skin pigmentation in C57BL\/6 mice affect optical bioluminescence quantitation. Molecular Imaging and Biology. 13 (6), 1114-1123 (2011).","journal-title":"Molecular Imaging and Biology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3389\/fimmu.2018.01376","type":"journal-article","article-title":"More than skin deep: autophagy is vital for skin barrier function","volume":"9","author":"Sil","year":"2018","unstructured":"Sil, P., Wong, S. W., Martinez, J. More than skin deep: autophagy is vital for skin barrier function. Frontiers in Immunology. 9, 1376 (2018).","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","type":"journal-article","article-title":"Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis","volume":"160","author":"Chen","year":"2015","unstructured":"Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell. 160 (6), 1246-1260 (2015).","journal-title":"Cell"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","type":"journal-article","article-title":"High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities","volume":"163","author":"Hart","year":"2015","unstructured":"Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell. 163 (6), 1515-1526 (2015).","journal-title":"Cell"},{"issue":"6264","key":"ref38","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.aac7041","type":"journal-article","article-title":"Identification and characterization of essential genes in the human genome","volume":"350","author":"Wang","year":"2015","unstructured":"Wang, T. et al. Identification and characterization of essential genes in the human genome. Science. 350 (6264), 1096-1101 (2015).","journal-title":"Science"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","type":"journal-article","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M., Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research. 30 (1), 207-210 (2002).","journal-title":"Nucleic Acids Research"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ng.3312","type":"journal-article","article-title":"The European Genome-phenome Archive of human data consented for biomedical research","volume":"47","author":"Lappalainen","year":"2015","unstructured":"Lappalainen, I., et al. The European Genome-phenome Archive of human data consented for biomedical research. Nature Genetics. 47 (7), 692-695 (2015).","journal-title":"Nature Genetics"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","type":"journal-article","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery. 2 (5), 401-404 (2012).","journal-title":"Cancer Discovery"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMp1607591","type":"journal-article","article-title":"Toward a shared vision for cancer genomic data","volume":"375","author":"Grossman","year":"2016","unstructured":"Grossman, R. L., et al. Toward a shared vision for cancer genomic data. New England Journal of Medicine. 375 (12), 1109-1112 (2016).","journal-title":"New England Journal of Medicine"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/63186\/a-robust-discovery-platform-for-identification-novel-mediators","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:15:59Z","timestamp":1792613759000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/63186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":42,"journal-issue":{"issue":"181","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3791\/63186","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]}}}